Home Newsfeeds ‘U.S. Senate’s banking panel chairman: Congress unlikely to tighten banking rules’ -Reuters

‘U.S. Senate’s banking panel chairman: Congress unlikely to tighten banking rules’ -Reuters

https://www.reuters.com/world/us/us-senates-banking-panel-chairman-congress-unlikely-tighten-banking-rules-2023-03-14/

byMichael Horton

March 14, 2023

1 minute read

https://www.reuters.com/world/us/us-senates-banking-panel-chairman-congress-unlikely-tighten-banking-rules-2023-03-14/

Here’s How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today

By Benzinga Insights

March 28, 3:30 PM

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 5.94% on an annualized basis…

VRTX

B of A Securities Maintains Underperform on Virgin Galactic Hldgs, Lowers Price Target to $5

By Benzinga Newsdesk

August 18, 9:44 AM

B of A Securities analyst Ronald Epstein maintains Virgin Galactic Hldgs (NYSE:SPCE) with a Underperform and lowers the price target from $7 to $5.

SPCE

News

January’s Harsh Weather Curbs Argo Blockchain’s Crypto Production, Reveals Operational Update

By Benzinga Newsdesk

February 5, 3:13 AM

Argo Blockchain plc, a global leader in cryptocurrency mining (LSE:ARB)(NASDAQ:ARBK), is pleased to provide the following operational update for January 2024. During the month of January, the Company mined 124 Bitcoin,

ARBK

Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating A Extension In Time To Intracranial Progression For Patients With Brain Metastases From Non-Small Cell Lung Cancer

By Benzinga Newsdesk

March 27, 9:30 AM

The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Fields and supportive care compared to 11.3 months for patients treated with supportive care

NVCR

‘U.S. Senate’s banking panel chairman: Congress unlikely to tighten banking rules’ -Reuters

Related Posts

Here’s How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today

B of A Securities Maintains Underperform on Virgin Galactic Hldgs, Lowers Price Target to $5

January’s Harsh Weather Curbs Argo Blockchain’s Crypto Production, Reveals Operational Update

Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating A Extension In Time To Intracranial Progression For Patients With Brain Metastases From Non-Small Cell Lung Cancer